Home Categories Pharmaceutical intermediates ((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl4-methylbenzenesulfonate
BD5619153

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl4-methylbenzenesulfonate , 98% , 149809-43-8

CAS NO.:149809-43-8

Empirical Formula: C21H21F2N3O4S

Molecular Weight: 449.47

MDL number: MFCD13195567

EINECS: 1308068-626-2

Pack Size Price Stock Quantity
1g RMB113.60 In Stock
5g RMB395.20 In Stock
25g RMB1380.80 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 100-102°C
Boiling point: 608.1±65.0 °C(Predicted)
Density  1.40
storage temp.  -20°C Freezer, Under Inert Atmosphere
solubility  slightly sol. in Chloroform
form  powder to crystal
pka 2.75±0.10(Predicted)
color  White to Orange to Green
InChIKey DFWVLCJRFGIRAK-HRAATJIYSA-N
CAS DataBase Reference 149809-43-8(CAS DataBase Reference)

Description and Uses

(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester is a pharmaceutical intermediate ingredient for Posaconazole is one of the newest triazole antifungal agents approved by the FDA for the prevention of invasive Aspergillus and Candida infections in immunocompromised patients. Such patients include haematopoietic stem cell transplant patients with graft-versus-host disease and patients with haematological malignancies undergoing chemotherapy.

Posaconazole intermediate. Antifungal agent.

Safety

Symbol(GHS) 
GHS06,GHS08
Signal word  Danger
Hazard statements  H301-H311-H331-H341
Precautionary statements  P201-P202-P261-P264-P270-P271-P280-P302+P352-P304+P340-P308+P313-P310-P330-P361-P403+P233-P405-P501
HS Code  2934.99.4400

RELATED PRODUCTS